These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2985390)
41. [Comparative study of nuclear imaging with 99mTc-PMT, B ultrasound and CT in the diagnosis of hepatic tumors]. Wu ZM Zhonghua Fang She Xue Za Zhi; 1988 Dec; 22(6):329-33. PubMed ID: 2855051 [No Abstract] [Full Text] [Related]
42. Uptake of technetium-99m DISIDA by bone metastasis from a hepatoma. Pons F; Lomeña F; Calvet X; Bruix J; Catafau A; Ginés A; Herranz R; Setoain J Clin Nucl Med; 1988 Apr; 13(4):280-2. PubMed ID: 2836119 [TBL] [Abstract][Full Text] [Related]
43. [Usefulness of 99mTc-PMT cholescintigraphy in diagnosis a case of bone metastasis in hepatocellular carcinoma]. Inoue A; Imaeda T; Yanagawa S; Doi T Rinsho Hoshasen; 1989 Aug; 34(8):901-2. PubMed ID: 2555595 [No Abstract] [Full Text] [Related]
44. [Delayed Tc-99m-PMT imaging in the specific diagnosis of hepatocellular carcinoma]. Wu ZM Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):360-3. PubMed ID: 2854779 [TBL] [Abstract][Full Text] [Related]
45. Hepatobiliary imaging of functional and morphological changes following hepatic arterial embolization in hepatocellular carcinoma. Tai DI; Chen HY; Wang PW; Lee CH; Lee TY; Chen WJ; Chen JJ; Chang Chien CS J Nucl Med; 1995 Sep; 36(9):1590-4. PubMed ID: 7658215 [TBL] [Abstract][Full Text] [Related]
46. Quantitative analysis by digital computer of 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) hepatogram in diffuse parenchymal liver diseases. Narabayashi I; Sugimura K; Ishido N; Kajita A Eur J Nucl Med; 1987; 13(6):285-7. PubMed ID: 3665977 [TBL] [Abstract][Full Text] [Related]
47. Subtraction scintigraphy with 67Ga-citrate and 99mTc-colloid in the diagnosis of intrahepatic masses. Oyamada H; Kawai H; Fukukita H; Nagaiwa K; Terui S; Uehara T; Hasegawa H Radioisotopes; 1980 Jun; 29(6):272-8. PubMed ID: 6259700 [TBL] [Abstract][Full Text] [Related]
48. Detection of hepatoma in liver cirrhosis. Moreau R; Soussaline F; Chauvaud S; Parmentier C; Di Paola R; Charbord P; Tubiana M Eur J Nucl Med; 1977 Sep; 2(3):183-8. PubMed ID: 199443 [TBL] [Abstract][Full Text] [Related]
49. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan. Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436 [TBL] [Abstract][Full Text] [Related]
50. Tc-99m HIDA hepatobiliary agent in the diagnosis of pulmonary metastasis from hepatocellular carcinoma. Wang PW; Tai DI; Chen HY Clin Nucl Med; 1991 Feb; 16(2):120-3. PubMed ID: 1848494 [TBL] [Abstract][Full Text] [Related]
51. Hepatoma visualization with Tc-99m pyridoxylidene glutamate. Utz JA; Lull RJ; Anderson JH; Lambrecht RW; Brown JM; Henry W J Nucl Med; 1980 Aug; 21(8):747-9. PubMed ID: 6249896 [TBL] [Abstract][Full Text] [Related]
52. Gallium scanning in the diagnosis of hepatocellular carcinoma: a clinicopathological study of 45 patients. Nagasue N Clin Radiol; 1983 Mar; 34(2):139-42. PubMed ID: 6297843 [TBL] [Abstract][Full Text] [Related]
53. [Usefulness of 99mTc-PMT SPECT and 18F-FDG PET in diagnosing orbital metastasis of hepatocellular carcinoma]. Hosokawa C; Kawabe J; Okamura T; Kamino T; Ikeda H; Ochi H; Onoyama Y Kaku Igaku; 1994 Oct; 31(10):1237-42. PubMed ID: 7807727 [TBL] [Abstract][Full Text] [Related]
54. [Hepatobiliary functions in primary biliary cirrhosis--assessment with 99mTc-PMT hepatobiliary scintigraphy]. Imai Y Kaku Igaku; 1994 Mar; 31(3):249-56. PubMed ID: 8176863 [TBL] [Abstract][Full Text] [Related]
55. [Estimation of total liver uptake and liver uptake per unit of liver volume of Tc-99m(Sn)-N-pyridoxyl-5-methyltryptophan (Tc-99m-PMT) using SPECT]. Nakamura K; Maeda H; Nakagawa T; Sakuma H; Kitano T; Takeda K; Yamaguchi N Kaku Igaku; 1988 Dec; 25(12):1363-9. PubMed ID: 3266887 [No Abstract] [Full Text] [Related]
56. Technetium-99m glucoheptonate as a scanning agent in hepatocellular carcinoma. Esser JD; Kew MC; Tobias M; Winterton R; Savitch I; Levin J Clin Nucl Med; 1985 Aug; 10(8):586-8. PubMed ID: 2994936 [TBL] [Abstract][Full Text] [Related]
57. Accumulation of Tc-99m PMT in adrenal metastasis of hepatoma. Miyake H; Takeoka H; Wakisaka M; Mori H Clin Nucl Med; 1991 Dec; 16(12):940-1. PubMed ID: 1663015 [No Abstract] [Full Text] [Related]
58. [Comparison of bone, gallium and hepatobiliary scintigraphy in the detection of bone metastases in hepatoma]. Tahara T; Ichiya Y; Kuwabara Y; Otsuka M; Masuda K Kaku Igaku; 1988 Dec; 25(12):1337-44. PubMed ID: 2854867 [No Abstract] [Full Text] [Related]
59. Comparison of 99mTc-N-pyridoxyl-5-methyltryptophan and 99mTc-N-(3-bromo-2,4,6-trimethylacetanilide)-iminodiace tate as hepatobiliary radiopharmaceuticals in rats. Fritzberg AR; Bloedow DC; Eshima D; Johnson DL J Pharm Sci; 1984 Dec; 73(12):1861-3. PubMed ID: 6527280 [TBL] [Abstract][Full Text] [Related]
60. Discordant hepatic uptake of Tc-99m NGA and Tc-99m PMT in a patient with hepatoma. Aburano T; Shuke N; Yokoyama K; Tonami N; Hisada K; Tanei M; Terada M; Unoura M; Kobayashi K Clin Nucl Med; 1992 Oct; 17(10):793-6. PubMed ID: 1330392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]